Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-12-11 09:09 am Sale | 13G | EVELO BIOSCIENCES INC EVLO | FMR LLC | 0 0% | -1,326,267 (Position Closed) | View |
| 2023-11-13 09:02 am Sale | 13G | EVELO BIOSCIENCES INC EVLO | FMR LLC | 1,326,267 7.041% | -1,125,985 (-45.92%) | View |
| 2023-08-10 08:19 am Purchase | 13G | EVELO BIOSCIENCES INC EVLO | FMR LLC | 2,452,252 14.75% | 2,325,827 (+1839.69%) | View |
| 2023-07-21 3:46 pm Purchase | 13G | EVELO BIOSCIENCES INC EVLO | Horizon Technology Finance Corp HRZN | 2,164,502 11.5% | 2,164,502 (New Position) | View |
| 2023-07-21 08:00 am Purchase | 13G | EVELO BIOSCIENCES INC EVLO | HarbourVest Partners L.P. | 1,451,876 8.8% | 1,451,876 (New Position) | View |
| 2023-07-13 5:00 pm Purchase | 13D | EVELO BIOSCIENCES INC EVLO | Flagship Ventures Fund V L.P. | 7,932,624 42.2% | 7,932,624 (New Position) | View |
| 2023-07-10 10:20 am Purchase | 13G | EVELO BIOSCIENCES INC EVLO | FMR LLC | 126,425 2.257% | 126,425 (New Position) | View |
| 2023-06-12 08:21 am Sale | 13G | EVELO BIOSCIENCES INC EVLO | FMR LLC | 9,795,646 8.746% | -6,632,705 (-40.37%) | View |
| 2023-02-21 06:10 am Purchase | 13D | EVELO BIOSCIENCES INC EVLO | DNCA FINANCE | 445 4.96% | 445 (New Position) | View |
| 2023-02-14 06:10 am Unchanged | 13G | EVELO BIOSCIENCES INC EVLO | HarbourVest Partners L.P. | 3,063,505 2.8% | 0 (Unchanged) | View |
| 2023-02-09 10:59 am Purchase | 13G | EVELO BIOSCIENCES INC EVLO | FMR LLC | 16,428,351 14.987% | 8,409,359 (+104.87%) | View |
| 2023-02-02 1:43 pm Purchase | 13G | EVELO BIOSCIENCES INC EVLO | CREDIT SUISSE AG | 3,678,388 3.35% | 111,901 (+3.14%) | View |
| 2022-11-21 08:28 am Sale | 13D | EVELO BIOSCIENCES INC EVLO | DNCA FINANCE | 0 0% | -920 (Position Closed) | View |
| 2022-08-23 09:32 am Purchase | 13D | EVELO BIOSCIENCES INC EVLO | DNCA FINANCE | 920 3.63% | 232 (+33.72%) | View |
| 2022-06-01 5:01 pm Purchase | 13D | EVELO BIOSCIENCES INC EVLO | Flagship Ventures Fund V L.P. | 50,427,328 46.7% | 27,397,259 (+118.96%) | View |
| 2022-02-14 1:25 pm Purchase | 13G | EVELO BIOSCIENCES INC EVLO | CREDIT SUISSE AG | 3,566,487 6.67% | 860,976 (+31.82%) | View |
| 2022-02-09 09:11 am Purchase | 13G | EVELO BIOSCIENCES INC EVLO | FMR LLC | 8,018,992 14.999% | 1,215,627 (+17.87%) | View |
| 2021-12-28 3:58 pm Purchase | 13D | EVELO BIOSCIENCES INC EVLO | DNCA FINANCE | 688 5.03% | 688 (New Position) | View |
| 2021-02-16 07:59 am Purchase | 13G | EVELO BIOSCIENCES INC EVLO | HarbourVest Partners L.P. | 3,063,505 6.6% | 1,300,000 (+73.72%) | View |
| 2021-02-12 4:16 pm Purchase | 13G | EVELO BIOSCIENCES INC EVLO | CREDIT SUISSE AG | 2,705,511 5.86% | 2,705,511 (New Position) | View |